European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

Opus Genetics, Inc. (Nasdaq: IRD) ('Opus Genetics” or the 'Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Nationwide survey finds nearly half of people with inherited retinal disease waited more than five years for genetic ...

An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World ...

Belite Bio, Inc (NASDAQ: BLTE) ('Belite Bio®” or the 'Company”), a clinical-stage drug development company focused on ...

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. Cognition Therapeutics, Inc.

New research challenges concerns that tirzepatide harms the eyes, finding lower rates of diabetic retinopathy instead.

It isn't often that a share falls by this amount in a single session. The post Why is this ASX share crashing 97% today?

Nanoscope Therapeutics Inc., a biotechnology company focused on developing and commercializing novel, disease‑agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

When approved, ONS-5010/LYTENAVA™ will be the first and only FDA-approved ophthalmic formulation of bevacizumab supported by standardized manufacturing, FDA-approved labeling, and robust ...